AMERICAN JOURNAL OF TRANSPLANTATION
Scope & Guideline
Transforming lives through innovative transplantation research.
Introduction
Aims and Scopes
- Clinical Transplantation Studies:
The journal publishes studies that investigate clinical outcomes, complications, and management strategies in kidney, liver, heart, and other organ transplants, aiming to improve patient care and optimize transplant protocols. - Transplant Immunology:
Research on the immunological aspects of transplantation, including the mechanisms of rejection, the role of immune cells, and advances in immunosuppressive therapies, is a core focus, contributing to the understanding and management of transplant rejection. - Innovative Transplant Techniques and Technologies:
AJT showcases advancements in surgical techniques, such as robotic-assisted transplantation and machine perfusion technologies, which are crucial for enhancing graft viability and outcomes. - Ethical and Policy Issues in Transplantation:
The journal addresses the ethical considerations and policy implications surrounding organ donation, allocation, and transplantation practices, promoting equitable access to transplantation. - Emerging Therapies and Biomarkers:
Research on novel therapies, including gene therapies, monoclonal antibodies, and the use of biomarkers for monitoring transplant health and predicting rejection, is emphasized to foster innovation in patient management.
Trending and Emerging
- Integration of Artificial Intelligence and Machine Learning:
Recent publications highlight the increasing use of AI and machine learning to predict transplant outcomes, optimize organ allocation, and enhance patient monitoring, showcasing a trend towards data-driven approaches in transplantation. - Focus on Social Determinants of Health:
There is a growing emphasis on understanding how social determinants affect access to transplantation and patient outcomes, indicating a shift towards a more holistic view of patient care. - Advancements in Xenotransplantation:
Research into xenotransplantation is gaining momentum, particularly studies exploring the use of genetically modified animal organs, reflecting an urgent need to address organ shortages. - Personalized Immunosuppression Strategies:
Emerging studies focus on tailoring immunosuppressive therapies based on individual patient profiles, including genetic and immunological factors, to improve transplant success rates. - Vaccine Response in Transplant Recipients:
There is an increasing body of research on the immune response to vaccinations, particularly regarding COVID-19, addressing the unique challenges faced by transplant recipients in maintaining immunity.
Declining or Waning
- Traditional Immunosuppressive Protocols:
There has been a reduction in studies focusing exclusively on traditional immunosuppressive regimens, as the field increasingly explores personalized medicine approaches and novel therapies that may offer better outcomes. - Basic Science Research Without Clinical Relevance:
The journal has seen fewer submissions that focus solely on basic science without a clear connection to clinical applications, reflecting a trend towards research that directly impacts transplant practices. - Single-Organ Transplant Studies:
Research specifically targeting outcomes in isolated organ transplants (e.g., kidney only) is waning in favor of studies that address multi-organ transplants or combined approaches, indicating a shift towards a broader scope of transplantation. - Repetitive Studies on Established Protocols:
There is a noticeable decrease in studies that replicate existing knowledge on well-established transplant protocols without offering new insights or advancements, as the journal encourages more innovative and impactful research. - Focus on Older Donor Outcomes:
As the field embraces the use of marginal donors, studies solely dedicated to the outcomes of older donors are becoming less frequent, reflecting a broader acceptance of diverse donor profiles in transplantation.
Similar Journals
TRANSPLANT INTERNATIONAL
Exploring Breakthroughs in Transplant MedicineTRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.
CLINICAL TRANSPLANTATION
Pioneering Research in Organ TransplantationClinical Transplantation is a leading journal in the field of transplantation medicine, published by Wiley. With an ISSN of 0902-0063 and an E-ISSN of 1399-0012, this prestigious journal has been pivotal in advancing the understanding of clinical practices and innovative research in transplantation since its inception in 1989. Based in the United Kingdom, it is recognized within the Category Quartiles as Q2 in Transplantation and boasts a respectable Scopus rank, placing it #20 out of 54 in its field, highlighting its significance. The journal serves as a platform for disseminating peer-reviewed articles that encompass a wide range of topics, from organ transplantation techniques to post-operative care and immunology, catering to researchers, healthcare professionals, and students alike. As the field progresses towards more personalized and effective treatment approaches, Clinical Transplantation remains committed to providing insight and fostering excellence in research for the global transplantation community.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
Shaping the future of nephrology with evidence-based insights.CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and research in the fields of nephrology and hypertension. Since its inception in 1992, this journal has been an essential resource for professionals seeking to stay at the forefront of kidney health and blood pressure management. With a distinguished ranking in the top quartile (Q1) for both Internal Medicine and Nephrology as of 2023, the journal is recognized for its high impact, currently holding a Scopus rank of #16 out of 81 in Nephrology, positioning it in the 80th percentile. Although not an open access journal, it provides crucial insights and expert opinions that cater to researchers, clinicians, and students committed to improving patient outcomes through evidence-based practice. The journal continues to emphasize its objectives of disseminating pivotal findings and fostering discussions that bridge the gap between clinical practice and research, making it an invaluable asset in the evolving landscape of nephrology and hypertension.
Transplant Immunology
Advancing the Frontiers of Transplant Science.Transplant Immunology is a leading interdisciplinary journal published by Elsevier, dedicated to the advancing field of transplant science and immunology. With a strong reputation in the academic community, it currently holds a significant position in the Q3 quartile in both the Immunology and Allergy categories, as well as Q2 in Transplantation, reflecting its impact and relevance within these fields. Since its inception in 1993, the journal has explored a broad spectrum of topics, ranging from immunological mechanisms to clinical aspects of transplantation, serving as a vital resource for researchers, healthcare professionals, and students alike. Although it is not an open-access journal, it offers critical insights and innovative research findings that bridge theoretical knowledge and practical application, thereby enhancing our understanding of transplant immunology. As the field continues to evolve, Transplant Immunology remains committed to publishing high-quality studies that advance the dialogue between immunology and transplantation, fostering collaboration and discovery.
Transplantation Direct
Pioneering Open Access Solutions in Transplantation ScienceTransplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.
TRANSPLANTATION
Advancing the Frontiers of Transplantation Science.TRANSPLANTATION is a premier journal in the field of organ transplantation, published by Lippincott Williams & Wilkins, that has been a cornerstone of transplantation research since its inception in 1963. With an impressive impact factor cementing its status, this journal is categorized in the top quartile (Q1) of its field, currently ranking 6th out of 54 in the Scopus Medicine Transplantation category, placing it in the 89th percentile. The journal publishes original research, clinical studies, and reviews that significantly advance our understanding of transplantation science, ensuring that professionals, researchers, and students remain informed of the latest developments. Although it is not an open-access journal, it offers valuable insights that contribute to enhancing practice and improving outcomes in transplantation medicine, making it an essential resource for anyone involved in this dynamic and impactful discipline.
Progress in Transplantation
Connecting Researchers and Clinicians for ProgressProgress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.
ESC Heart Failure
Empowering healthcare professionals with vital cardiovascular insights.ESC Heart Failure is a premier academic journal dedicated to the field of cardiology, specifically focusing on heart failure and its management. Published by WILEY PERIODICALS, INC, this esteemed journal has been an open access publication since 2014, making cutting-edge research readily accessible to a global audience. With its impressive impact factor and recent classification as a Q1 journal in Cardiology and Cardiovascular Medicine for 2023, ESC Heart Failure stands out as a leading resource with a Scopus ranking of #68 out of 387 in its field, placing it in the 82nd percentile. The journal aims to disseminate vital research findings, reviews, and clinical insights that advance the understanding and treatment of heart failure, thereby supporting healthcare professionals, researchers, and students in enhancing patient care. Its commitment to quality and relevance makes ESC Heart Failure an essential publication for anyone involved in cardiovascular medicine.
Current Opinion in Organ Transplantation
Leading the Dialogue in Organ Transplant ResearchCurrent Opinion in Organ Transplantation, published by Lippincott Williams & Wilkins, serves as a leading journal in the fields of immunology and transplantation, providing insightful reviews and expert opinions that shape the discourse in these vital areas of medical research. With an impact factor showcasing its significance and influence in the academic community, this journal is ranked in the Q2 category for both Immunology and Transplantation according to the 2023 metrics, affirming its essential role in advancing knowledge and understanding. Spanning from its inception in 2001 through to 2024, Current Opinion in Organ Transplantation offers a platform for researchers, professionals, and students to engage with the latest advancements and trends, contributing to the ongoing dialogue that drives innovation in organ transplantation and immunological therapies. Although the journal does not currently offer open access options, its rigorous peer-review process and reputable publisher ensure the highest quality of research dissemination, making it an invaluable resource for those invested in the future of organ transplantation.
Annals of Transplantation
Innovating Care Through Groundbreaking ResearchAnnals of Transplantation is a renowned academic journal published by INT SCIENTIFIC INFORMATION, INC, dedicated to the field of transplantation medicine. With a strong historical presence since its inception in 1996, this journal continues to provide a vital platform for disseminating innovative research, clinical studies, and review articles that contribute significantly to the ever-evolving landscape of organ transplantation. Holding a respectable Q2 ranking in the field of transplantation and a Q3 ranking in broader medicine categories as of 2023, the journal stands out with an impactful repository of knowledge that caters to a diverse audience, including researchers, healthcare professionals, and students. While it currently does not operate under an open access model, the scholarly contributions within are crucial for advancing practices, policies, and outcomes in transplantation. Whether you are seeking to keep abreast of recent advances or looking to publish your own findings, Annals of Transplantation serves as an essential resource for fostering collaboration and innovation in medical science.